Carboplatin/taxane-induced gastrointestinal toxicity: a pharmacogenomics study on the SCOTROC1 trial

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Plasma advanced oxidative protein products are associated with anti-oxidative stress pathway genes and malaria in a longitudinal cohort

(2014) Guicheng Zhang et al.   MALARIA JOURNAL

VEGFA variants are associated with pre-school lung function, but not neonatal lung function

(2013) E. Kreiner-Møller et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Cumulative Genetic Risk Predicts Platinum/Taxane-Induced Neurotoxicity

(2013) S. McWhinney-Glass et al.   CLINICAL CANCER RESEARCH

Anti-VEGF/VEGFR Therapy for Cancer: Reassessing the Target

(2012) B. Sitohy et al.   CANCER RESEARCH

Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer

(2011) Robert A. Burger et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Phase 3 Trial of Bevacizumab in Ovarian Cancer

(2011) Timothy J. Perren et al.   NEW ENGLAND JOURNAL OF MEDICINE

The predictive value of genetic variations in the vascular endothelial growth factor A gene in metastatic colorectal cancer

(2010) T F Hansen et al.   PHARMACOGENOMICS JOURNAL

Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: A Korean population-based study

(2009) Hee Seung Kim et al.   GYNECOLOGIC ONCOLOGY

A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform

(2009) J F Deeken et al.   PHARMACOGENOMICS JOURNAL

Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients

(2008) H. Chang et al.   ANNALS OF ONCOLOGY

ABCB1 Genetic Variation Influences the Toxicity and Clinical Outcome of Patients with Androgen-Independent Prostate Cancer Treated with Docetaxel

(2008) T. M. Sissung et al.   CLINICAL CANCER RESEARCH